Bioprocessing Conference
2020-12-03
Online
Online
10:00
- 10:10
Welcome Address

Dr Jonathan Downey
Managing Director - ARTeSYN BioSolutions
10:15
- 10:25
Opening Remarks

Martin Shanahan
CEO, IDA
10:30
- 11:30
Plenary Session
Challenges facing the industry as technology develops at a rapid pace and new techniques are adopted. International perspectives on the future of the Irish biopharma sector in a post-Covid-Brexit world.

Barry Kennedy
CEO, Irish Manufacturing Research / Panel Moderator

Brendan McGrath
Brendan McGrath - Site Head and Vice President of Manufacturing - WuXi Biologics

Christine Gebski
Vice President, Product Management & Field Applications - REPLIGEN CORPORATION

Paul Keogh
Plant Director, Takeda Ireland

Rory Mullen
Head of Biopharma, IDA

Gary Hartnett
General Manager/VP - Janssen Sciences Ireland
11:40
- 12:00
Vaccines & COVID19

Professor Luke O’Neill
Chair of Biochemistry - Trinity College Dublin
12:05
- 12:25
Single use technologies

Jim Vogel
Founder & DIrector The BioProcess Institute
12:25
- 12:45
Cell & Gene Therapies

Dr Nina Bauer
Head of Commercial Gene Editing & Novel Modalities Business, ,Merck
12:45
- 13:00
Increasing lentiviral vector bioreactor yield with simplified execution using tangential flow depth filtration

Michael Bransby
Research and Development Director of Process Technology, Repligen
13:10
- 14:10
Panel Discussion – Addressing Future Skills Needs for the BioPharma Sector

Matt Moran
Director - BioPharmaChem Ireland /Panel Moderator

Paul Healy
Chief Executive, Skillnet Ireland

Barry Curry
Director of Project Management - Système

Dr. Ramesh Raghavendra
Centre Director & Founder of 3DWIT - SEAM

Geoffrey Allen
Imagineer - Mersus Technologies

Darrin Morrissey
CEO - NIBRT

Dr. Thomas Becker
Director Site Quality - Recipharm, Wasserburger Arzneimittelwerk GmbH
14:15
- 15:00
Panel Discussion – Game Changers – BioPharma and the Sustainability Challenge

David McCormack
Director, Sustainable Manufacturing, IMR / Panel Moderator

Daniel Howell
European RTC Manager, STERIS

Timmy Carey
Associate Director EHS&S - BioMarin Pharmaceutical Inc.

Inder Poonaji
Founder - Six Butterflies

Cian O’Brien
Head of Innovation, Digital & Engineering at Sanofi
15:05
- 16:05
Panel Discussion – Business Transformation – The Digital BioPharma Opportunity

Siobhan Fleming
Business Development Manager, Siemens / Panel Moderator

Emily Mitchell
Executive Director, Biometrics - PRAHS

David Kelaher
Chief Medical Officer - Pharmaspectra

Peter R. Levison
Executive Director Business Development - Pall Biotech

Dr Paul Dobson
Head of Data - Valitacell Ltd

Barry Curry
Director of Project Management - Système
16:10
- 16:30
Ireland, a global example for FDI

Professor Gerry Byrne
Managing Director - GB Innovation.
16:30
- 16:45
Closing Remarks

Dr Jonathan Downey
Managing Director - ARTeSYN BioSolutions
Select date to see events.